Skip to main content
. 2020 Sep 15;2(9):e0196. doi: 10.1097/CCE.0000000000000196

Figure 2.

Figure 2.

Pharmacodynamic activated partial thromboplastin time (aPTT) response to EP-7041 in humans following continuous IV administration for 5 d. At 0.6 mg/kg/hr, the mean increase in aPTT was 1.7 compared with baseline, importantly with no off-target change in prothrombin time (PT). In addition, the results highlight the rapid onset, prompt clearance, and predictable dose-related elevations in the pharmacodynamic marker, aPTT.